The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes

The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes

Abstract Background Psoriatic arthritis (PsA) is a chronic inflammatory arthritis which impacts significantly on the quality of life and work capacity of affected individuals. Recent evidence has shown that early control of inflammation in PsA leads to improved long-term outcomes. It is postulated t...

Full description

Bibliographic Details
Main Authors: Gabriele De Marco, Philip Helliwell, Dennis McGonagle, Paul Emery, Laura C. Coates, Elizabeth M. A. Hensor, Helena Marzo-Ortega
Format: Article
Language:English
Published: BMC 2017-07-01
Series:BMC Musculoskeletal Disorders
Subjects:
Psoriatic arthritis
Early diagnosis
Treatment-näive
TNF-inhibitor
Treat-to-target
Minimal disease activity
Online Access:http://link.springer.com/article/10.1186/s12891-017-1659-1

Internet

http://link.springer.com/article/10.1186/s12891-017-1659-1

Similar Items